1.Smyth, BPKeenan, E, O'Connor, JJ. Blood borne viral infection in Irish injecting drug users. Addiction 1998; 93: 1649–1656.
2.Smyth, R, Keenan, E, Dorman, A, O'Connor, JJ. Hepatitis C among drug users attending the National Dug Treatment Centre. Ir J Med Science 1995; 164: 267–268.
3.Smyth, BP, O'Connor, JJ, Barry, J, Keenan, E. Retrospective cohort study examining incidence of HIV and hepatitis C infection among injecting drug users in Dublin. J Epidemiol Comm Health 2003; 57: 310–311.
4.Freeman, AJ, Dore, GJ, Law, MJet al.Estimating progression to cirrhosis in chronic hepatitis C infection. Hepatology 2001; 34: 809–816.
5.National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C. Gastroenterology 2002; 123(6): 2082–2099.
6.Wasley, A, Alter, MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000; 20(1): 1–16.
7.Alter, MJ. The epidemiology of acute and chronic hepatitis C. Clin Liver Dis 1997; 1(3): 559–68.
8.Charlton, M. Hepatitis C infection in liver transplantation. Am J Transplant 2001; 1 (3): 197–203.
9.Wong, JB, McQuillan, GM, McHutchinson, JG, Poynard T, . Estimating future hepatitis C morbidity, mortality and costs in the United States. Am J Public Health 2000; 90: 1596–1601.
10.Deuffic, S, Buffat, L, Poynard, T, Valleron, AJ. Modelling the hepatitis C epidemic in France. Hepatology 1999; 31: 1014–1018.
11.Kavanagh, P, Moloney, J, Quinn, C, O'Kelly, E, McCormick, PA. High morbidity expected from cirrhosis in injecting drug users. Ir Med J 2003; 96(10): 303–305.
12.Corrao, G, Arico, S. Independent and combined action of hepatitis C infection and alcohol consumption on the risk of symptomatic liver disease. Hepatology 1998; 27: 914–919.
13.Westin, J, Lagging, LM, Spak, F el al. Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Viral Hepatology 2002; 9: 235–41.
14.Cox, G, Comiskey, C, Kelly, P. ROSIE Findings 4: Summary of 1-year outcomes: methadone modality. Dublin: National Advisory Committee on Drugs 2007.
15.MacManus, E, Fitzpatrick, C. Alcohol dependence and mood state in a population receiving methadone maintenance treatment. Ir J Psych Med 2007; 24(1): 19–22.
16.Gelb, AM, Richman, BL, Peyser, NP. Alcohol use in methadone maintenance clinics. Am J Drug Alcohol Abuse 1979; 6(3): 367–373.
17.Green, J, Jaffe, JH, Carlisi, JA, Zaks, A. Alcohol use in the opiate use cycle of the heroin addict. Int J Addiction 1978; 13(7): 1021–1033.
18.Hunt, DE, Strug, DL, Goldsmith, DS, Lipton, DS, Robertson, K, Truitt, L. Alcohol use and abuse: heavy drinking among methadone clients. Am J Drug Alcohol Abuse 1986; 12(1-2): 147–164.
19.Stastny, D, Potter, M. Alcohol abuse by patients undergoing methadone treatment programmes. Br J Addict 1991; 86(3): 307–310.
20.Hillebrand, J, Marsden, J, Finch, E, Strang, J. Excessive alcohol consumption and drinking expectations among clients in methadone maintenance. J Subst Abuse Treat 2001; 21(3): 155–160.
21.Ottomanelli, G. Methadone patients and alcohol abuse. J Subst Abuse Treat 1999; 16(2): 113–121.
22.McCusker, M. Influence of hepatitis C status on alcohol consumption in opiate users in treatment. Addiction 2001; 96: 1007–1014.
23.Best, D, Noble, A, Finch, E, Gossop, M, Sidwell, C, Strang, J. Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment. BMJ 1999; 319:290–291.
24.Saunders, JB, Aasland, OG, Babor, TF, de la Fuente, JR, Grant, M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. II. Addiction 1993; 88(6): 791–804.
25.Skipsey, K, Burleson, JA, Kranzler, HR. Utility of the AUDIT for identification of hazardous or harmful drinking in drug-dependent patients. Drug Alcohol Depend 1997; 45(3): 157–163.
26.Gossop, M, Marsden, J, Stewart, Det al.Substance use, health and social problems of service users at 54 drug treatment agencies – intake data from the National Treatment Outcome Research Study. Br J Psychiatry 1998; 173: 166–171.
27.Miller, WR. Motivational interviewing with problem drinkers. Behav Psychotherapy 1983; 11: 147–172.
28.Vasilaki, El, Hosier, SG, Cox, WM. The efficacy of motivational interviewing as a brief intervention for excessive drinking: a meta-analytic review. Alcohol 2006; 41 (3): 328–335.
29.Rubak, S, Sandbaek, A, Lauritzen, T, Christensen, B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract 2005; 55(513): 305–312.
30.Stein, MD, Charuvastra, A, Maksad, J, Anderson, BJ. A randomised trial of a brief alcohol intervention for needle exchangers (BRAINE). Addiction 2002; 97(6):691–700.
31.Miller, WR, Wilbourne, PL. Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction 2002; 97(3): 265–277.
32.van Beek, I, Dwyer, R, Dore, DG, Luo, K, Kaldor, JM. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ 1998; 317:433–437.
33.Anderson, P, Baumberg, B. Alcohol in Europe, London: Institute of Alcohol Studies; 2006.
34.Kelleher, C, Nic Gabhainn, S, Friel, Set al. Survey of Lifestyle, Attitudes and Nutrition (SLAN) and The Irish Health Behaviour in School-Aged Children Survey (HBSC), Galway: Centre for Health Promotion Studies, NUI, 2003.
35.Morgan, K, McGee, H, Watson, Det al.SLAN 2007: Survey of lifestyle, attitudes and nutrition in Ireland. Main Report. Dublin: Department of Health and Children, 2007
36.Cleary, A, Nixon, E, Fitzgerald M, . Psychological health and well being among young Irish adults. Ir J Psych Med 2007; 24: 139–144.
37.Anderson, RJ. Alcohol Aware Practice Pilot Study. Dublin. Irish College of General Practitioners, 2003